Evidence map›Paper›PMID 36618966›Full record

ArticleDisease markers2022

Coiled-Coil Domain-Containing Protein 45 Is a Potential Prognostic Biomarker and Is Associated with Immune Cell Enrichment of Hepatocellular Carcinoma.

Shuqing Liu, Lei Jia, Bing Quan, Guang Rong, Min Li, Ronggen Xie, Yanling Cai, Yuzhen Bi, Siyuan Han

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shuqing LiuDepartment of Infectious Diseases, SSL Central Hospital of Dongguan, Dongguan, 523000 Guangdong Province, China.
Lei JiaDepartment of Organ Transplantation, Affiliated Hospital of Guizhou Medical University, Guiyang, 550000 Guizhou Province, China.
Bing QuanDepartment of Infectious Diseases, SSL Central Hospital of Dongguan, Dongguan, 523000 Guangdong Province, China.
Guang RongDepartment of Hepatobiliary Surgery, SSL Central Hospital of Dongguan, Dongguan, 523000 Guangdong Province, China.
Min LiDepartment of Nephrology, SSL Central Hospital of Dongguan, Dongguan, 523000 Guangdong Province, China.
Ronggen XieDepartment of Infectious Diseases, SSL Central Hospital of Dongguan, Dongguan, 523000 Guangdong Province, China.
Yanling CaiDepartment of Infectious Diseases, SSL Central Hospital of Dongguan, Dongguan, 523000 Guangdong Province, China.
Yuzhen BiDepartment of Infectious Diseases, SSL Central Hospital of Dongguan, Dongguan, 523000 Guangdong Province, China.
Siyuan HanDepartment of Infectious Diseases, SSL Central Hospital of Dongguan, Dongguan, 523000 Guangdong Province, China.ORCID https://orcid.org/0000-0001-8419-1331
Dongguan People’s Hospital · CNGuiyang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The role of coiled-coil domain-containing protein 45 (CCDC45) in the development of hepatocellular carcinoma (HCC) has not been reported. The present study is aimed at investigating the expression and prognosis of CCDC45 in HCC and its relevance to immune infiltration. Methods: We conducted CCDC45 expression analysis using The Cancer Genome Atlas (TCGA) tumor database, the Human Protein Atlas (HPA) database, and the Tumor Immunological Evaluation Resource (TIMER). We used the University of Alabama at Birmingham Cancer data analysis Portal (UALCAN) database to show the correlation of CCDC45 with clinical features. We examined the prognostic impact of CCDC45 expression levels on HCC patients with the Kaplan-Meier mapper database. Genes coexpressed with CCDC45 and its regulators were also identified using LinkedOmics. The enriched Gene Ontology (GO) categories and associated signaling pathways were estimated using GO, Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Assay (GSEA) pathway data. Correlations between CCDC45 and cancer immune infiltration was analyzed through the TIMER and an integrated repository portal for Tumor-Immune System Interactions (TISIDB) databases. Results: The expression of CCDC45 was elevated in HCC tissues compared to adjacent liver tissues, and overexpression of CCDC45 was significantly correlated with tumor stage. Furthermore, HCC patients with CCDC45 overexpression had a shorter overall survival (OS). Functional network analysis indicated that CCDC45 was involved in homologous recombination, spliceosome, and DNA replication. Interestingly, CCDC45 expression was positively correlated with the level of immune cell infiltration. Conclusions: CCDC45 is associated with prognosis and immune infiltration of HCC and may be a potential therapeutic target for HCC.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsBiomarkersHumansPrognosisBiomarkers

Identifiers

PMID36618966
PMCPMC9815921
OpenAlexW4313331767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.